81 related articles for article (PubMed ID: 20214295)
1. [Treatment of hepatitis C in children].
Ciocca M; Cuarterolo M; Ramonet M
Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S34-5. PubMed ID: 20214295
[No Abstract] [Full Text] [Related]
2. Interferon + ribavirin combination therapy. Open new approach to treatment of patients with hepatitis C virus.
Iino S
Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):216-7. PubMed ID: 10379483
[No Abstract] [Full Text] [Related]
3. [Hepatitis C. Saving the liver].
Paul A
MMW Fortschr Med; 1999 Nov; 141(46):16. PubMed ID: 10795138
[No Abstract] [Full Text] [Related]
4. Interferon plus ribavirin: a cautionary note.
Macedo G; Ribeiro T
Am J Gastroenterol; 1999 Oct; 94(10):3087-8. PubMed ID: 10520894
[No Abstract] [Full Text] [Related]
5. [Therapeutic progresses of hepatitis C].
Ma QY
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):501-2. PubMed ID: 12939190
[No Abstract] [Full Text] [Related]
6. [New strategies for treatment of chronic hepatitis C].
Rizzetto M
Forum (Genova); 1999; 9(2 Suppl):1-11. PubMed ID: 11300125
[No Abstract] [Full Text] [Related]
7. 24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients.
van Leeuwen DJ; Yee LJ; Langner RG
Am J Gastroenterol; 2002 Feb; 97(2):497-8. PubMed ID: 11866304
[No Abstract] [Full Text] [Related]
8. [Concomitant nodular goiter during IFN and ribavirin treatment of HCV: a case report].
Lin F; Wang HF
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):163, 166. PubMed ID: 16700133
[No Abstract] [Full Text] [Related]
9. [Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)].
Juszczyk J; Bolewska B; Flieger J; Swietek K; Adamek B; Biskupska-Karasińska M; Dziambor AP; Boroń-Kaczmarska A; Wawrzynowicz-Syczewska M; Cianciara J; Kozłowska J; Daniluk J; Słomka M; Dudziak M; Zaborowski P; Gładysz A; Piszko P; Gonciarz Z; Mazur W; Machniak M; Kryczka W; Zarebska-Michaluk D; Trocha H; Witczak-Malinowska K; Lakomy E; Kuydowicz J; Niwicka-Michałowska A
Pol Merkur Lekarski; 2001 Oct; 11(64):340-3. PubMed ID: 11770315
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic hepatitis C: present and future].
Hezode C; Dhumeaux D
Gastroenterol Clin Biol; 2000 May; 24(5):533-5. PubMed ID: 10891741
[No Abstract] [Full Text] [Related]
12. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
Savoye G; Goria O; Herve S; Riachi G; Noblesse I; Bastien L; Courville P; Lerebours E
Gastroenterol Clin Biol; 2000; 24(6-7):679. PubMed ID: 10962394
[No Abstract] [Full Text] [Related]
13. Ribavirin in chronic hepatitis C: past and future.
Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
[No Abstract] [Full Text] [Related]
14. Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study.
Andreone P; Cursaro C; Gramenzi A; Fiorino S; Di Giammarino L; Miniero R; D'Errico A; Grigioni WF; Gasbarrini G; Bernardi M
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):688-94. PubMed ID: 10730561
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
Hamidah A; Yong JF; Zulkifli HI; Jamal R
Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
[TBL] [Abstract][Full Text] [Related]
16. [Treatment for chronic hepatitis C, more opportunity, more challenge].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):481-3. PubMed ID: 19912676
[No Abstract] [Full Text] [Related]
17. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
[TBL] [Abstract][Full Text] [Related]
18. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.
Wirth S; Lang T; Gehring S; Gerner P
Hepatology; 2002 Nov; 36(5):1280-4. PubMed ID: 12395341
[TBL] [Abstract][Full Text] [Related]
19. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].
Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):486-7. PubMed ID: 19912678
[No Abstract] [Full Text] [Related]
20. Combination treatment for hepatitis C can be hazardous in patients co-infected with HIV.
Schvarcz R; Moberg L; Sönnerborg A
Antivir Ther; 1998; 3(4):233-4. PubMed ID: 10682144
[No Abstract] [Full Text] [Related]
[Next] [New Search]